Back to results

Washington University in St. Louis

Nanoscale Enhancement of Photosensitized Radionuclide Stimulated Therapy

Abstract

dc:description.abstract

<p>Photodynamic therapy (PDT) provides efficient tumor killing through the generation of reactive oxygen species (ROS) from the optical excitation of a photosensitizer (PS). Furthermore, this mechanism is highly immune stimulating, providing systemic tumor immunity with a reduction in metastasis. However, these materials had previously been limited by their dependence upon external light sources, allowing treatment of only laser-accessible malignancy. With the recent development of photosensitized radiation stimulated therapy (PRaST) this depth dependence is broken through co-localization of radionuclides and semiconducting photosensitizers. This dissertation focuses on the enhancement of titanium dioxide (TiO2) based PRaST agents through understanding of TiO2 material parameters as well as adsorbent surface coatings to enhance therapeutic outcomes. TiO2 has several known crystal phases and can be generated from atomic clusters to micrometer sizes. To improve its therapeutic potential, we first investigated the effect these parameters had on its primary constraints, namely ROS generation and biodistribution, finding an interplay between 5 nm and 25 nm TiO2 crystal domains. Furthermore, we sought to overcome the central tumor resistance mechanism to PDT, that of oxygen dependence. ROS generation from molecular PS traditionally use NIR, optical excitation of electrons whose energy is then transferred to associated oxygen. Nanoscale TiO2 can use both electron and hole intersystem crossing, which generates ROS from adsorbed oxygen and water. To enhance this pathway, we investigated the ability of chromium VI ions to increase TiO2 hole flux as well as the ability of adsorbed dichromate to act as an oxygen independent metallo-therapeutic. Finally, we develop a polymer stabilized perfluorocarbon nanoemulsion able to be tracked with near-infrared fluorescent imaging and increase the oxygenation of hypoxic tumor tissue for the duration of PRaST. This can help to both boost ROS generation and normalize tumor microenvironments. Combined these developments point to new nano-design strategies to improve upon novel PRaST, optimizing the particles to both improve ROS generation and decrease tumor resistance.</p>

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Biomedical Engineering
Year dc:date.available
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lane, Daniel Douglas
Contributors dc:contributor
  • Samuel Achilefu
  • Abdel Kareem Azab, Gregory M. Lanza, Srikanth Singamaneni, Hong Chen,

Subjects

dc:subject × 9

Rights

dc:rights
Statement dc:rights
  • I have not registered my thesis with the U.S. Copyright Office, and do not intend to.
Language dc:language
English (en)

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:openscholarship.wustl.edu:eng_etds-1660

Chain of custody

source
Harvested from
Washington University in St. Louis
Base URL
openscholarship.wustl.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Lane, Daniel Douglas. Nanoscale Enhancement of Photosensitized Radionuclide Stimulated Therapy. Dissertation thesis, 2021. https://doi.org/10.7936/ha91-8a31